OQS
EVH icon

Occudo Quantitative Strategies’s Evolent Health EVH Stock Holding History

Occudo Quantitative Strategies’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,536
Closed -$378K – 822
2024
Q1 		$378K Buy
11,536
+734
+7% +$23.4K 0.07% 397
2023
Q4 		$357K Buy
10,802
+3,014
+39% +$85.3K 0.05% 488
2023
Q3 		$212K Buy
+7,788
New +$216K 0.03% 784
2022
Q4 		– Sell
-152,326
Closed -$5.47M – 1092
2022
Q3 		$5.47M Buy
152,326
+62,271
+69% +$2.19M 0.43% 26
2022
Q2 		$2.77M Buy
90,055
+24,594
+38% +$717K 0.23% 114
2022
Q1 		$2.11M Sell
65,461
-10,753
-14% -$282K 0.18% 162
2021
Q4 		$2.11M Buy
76,214
+25,857
+51% +$742K 0.19% 148
2021
Q3 		$1.56M Buy
+50,357
New +$1.21M 0.19% 140
2021
Q2 		– Sell
-10,025
Closed -$203K – 934
2021
Q1 		$203K Sell
10,025
-5,115
-34% -$97.3K 0.04% 615
2020
Q4 		$243K Buy
+15,140
New +$200K 0.08% 479

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Occudo Quantitative Strategies's EVH Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 11,536 shares — an estimated $378K sold.

Occudo Quantitative Strategies first reported a position in EVH in Q4 2020 and held it in 10 quarters. The position peaked at $5.47M in Q3 2022. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 11,536 Evolent Health shares in Q2 2024, an estimated $378K.
  • Occudo Quantitative Strategies first reported a position in Evolent Health in Q4 2020 and held it in 10 quarters.
  • Occudo Quantitative Strategies's Evolent Health position peaked at $5.47M in Q3 2022.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.